Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 80

1.

Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection.

Nalpas B, Lavialle-Meziani R, Plancoulaine S, Jouanguy E, Nalpas A, Munteanu M, Charlotte F, Ranque B, Patin E, Heath S, Fontaine H, Vallet-Pichard A, Pontoire D, Bourlière M, Casanova JL, Lathrop M, Bréchot C, Poynard T, Matsuda F, Pol S, Abel L.

Gut. 2010 Aug;59(8):1120-6. doi: 10.1136/gut.2009.202267. Epub 2010 Jun 29.

PMID:
20587546
2.

A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon.

Kong XF, Vogt G, Chapgier A, Lamaze C, Bustamante J, Prando C, Fortin A, Puel A, Feinberg J, Zhang XX, Gonnord P, Pihkala-Saarinen UM, Arola M, Moilanen P, Abel L, Korppi M, Boisson-Dupuis S, Casanova JL.

Hum Mol Genet. 2010 Feb 1;19(3):434-44. doi: 10.1093/hmg/ddp507. Epub 2009 Oct 31.

3.

Interplay between influenza A virus and the innate immune signaling.

Ehrhardt C, Seyer R, Hrincius ER, Eierhoff T, Wolff T, Ludwig S.

Microbes Infect. 2010 Jan;12(1):81-7. doi: 10.1016/j.micinf.2009.09.007. Epub 2009 Sep 25. Review.

PMID:
19782761
4.

IFNGR1 polymorphisms in Thai malaria patients.

Naka I, Patarapotikul J, Hananantachai H, Tokunaga K, Tsuchiya N, Ohashi J.

Infect Genet Evol. 2009 Dec;9(6):1406-9. doi: 10.1016/j.meegid.2009.08.004. Epub 2009 Aug 25.

PMID:
19712753
5.

Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency.

Vinh DC, Masannat F, Dzioba RB, Galgiani JN, Holland SM.

Clin Infect Dis. 2009 Sep 15;49(6):e62-5. doi: 10.1086/605532.

6.

A regulatory polymorphism in interferon-gamma receptor 1 promoter is associated with the susceptibility to chronic hepatitis B virus infection.

Zhou J, Chen DQ, Poon VK, Zeng Y, Ng F, Lu L, Huang JD, Yuen KY, Zheng BJ.

Immunogenetics. 2009 Jun;61(6):423-30. doi: 10.1007/s00251-009-0377-8. Epub 2009 Jun 2.

PMID:
19488747
7.

A partial form of recessive STAT1 deficiency in humans.

Chapgier A, Kong XF, Boisson-Dupuis S, Jouanguy E, Averbuch D, Feinberg J, Zhang SY, Bustamante J, Vogt G, Lejeune J, Mayola E, de Beaucoudrey L, Abel L, Engelhard D, Casanova JL.

J Clin Invest. 2009 Jun;119(6):1502-14. doi: 10.1172/JCI37083. Epub 2009 May 11.

8.

BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy.

Liu J, Tran V, Leung AS, Alexander DC, Zhu B.

Hum Vaccin. 2009 Feb;5(2):70-8. Epub 2009 Feb 20. Review.

PMID:
19164935
9.

Two patients with complete defects in interferon gamma receptor-dependent signaling.

Noordzij JG, Hartwig NG, Verreck FA, De Bruin-Versteeg S, De Boer T, Van Dissel JT, De Groot R, Ottenhoff TH, Van Dongen JJ.

J Clin Immunol. 2007 Sep;27(5):490-6. Epub 2007 May 21.

PMID:
17514500
10.
11.

A case of interleukin-12 receptor beta-1 deficiency with recurrent leishmaniasis.

Sanal O, Turkkani G, Gumruk F, Yel L, Secmeer G, Tezcan I, Kara A, Ersoy F.

Pediatr Infect Dis J. 2007 Apr;26(4):366-8.

PMID:
17414409
12.

IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan.

Salih MA, Ibrahim ME, Blackwell JM, Miller EN, Khalil EA, ElHassan AM, Musa AM, Mohamed HS.

Genes Immun. 2007 Jan;8(1):75-8. Epub 2006 Nov 30.

13.

Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.

Minegishi Y, Saito M, Morio T, Watanabe K, Agematsu K, Tsuchiya S, Takada H, Hara T, Kawamura N, Ariga T, Kaneko H, Kondo N, Tsuge I, Yachie A, Sakiyama Y, Iwata T, Bessho F, Ohishi T, Joh K, Imai K, Kogawa K, Shinohara M, Fujieda M, Wakiguchi H, Pasic S, Abinun M, Ochs HD, Renner ED, Jansson A, Belohradsky BH, Metin A, Shimizu N, Mizutani S, Miyawaki T, Nonoyama S, Karasuyama H.

Immunity. 2006 Nov;25(5):745-55.

14.

Posttranslational modifications of NEMO and its partners in NF-kappaB signaling.

Sebban H, Yamaoka S, Courtois G.

Trends Cell Biol. 2006 Nov;16(11):569-77. Epub 2006 Sep 20. Review.

PMID:
16987664
15.

Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.

Chapgier A, Boisson-Dupuis S, Jouanguy E, Vogt G, Feinberg J, Prochnicka-Chalufour A, Casrouge A, Yang K, Soudais C, Fieschi C, Santos OF, Bustamante J, Picard C, de Beaucoudrey L, Emile JF, Arkwright PD, Schreiber RD, Rolinck-Werninghaus C, Rösen-Wolff A, Magdorf K, Roesler J, Casanova JL.

PLoS Genet. 2006 Aug 18;2(8):e131.

16.

Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection.

Chackerian AA, Chen SJ, Brodie SJ, Mattson JD, McClanahan TK, Kastelein RA, Bowman EP.

Infect Immun. 2006 Nov;74(11):6092-9. Epub 2006 Aug 21.

17.

Novel mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infections.

Storgaard M, Varming K, Herlin T, Obel N.

Scand J Immunol. 2006 Aug;64(2):137-9.

18.

Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection.

Cruz A, Khader SA, Torrado E, Fraga A, Pearl JE, Pedrosa J, Cooper AM, Castro AG.

J Immunol. 2006 Aug 1;177(3):1416-20.

19.

X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production.

Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku CL, Puel A, Frucht DM, Christel K, von Bernuth H, Jouanguy E, Feinberg J, Durandy A, Senechal B, Chapgier A, Vogt G, de Beaucoudrey L, Fieschi C, Picard C, Garfa M, Chemli J, Bejaoui M, Tsolia MN, Kutukculer N, Plebani A, Notarangelo L, Bodemer C, Geissmann F, Israël A, Véron M, Knackstedt M, Barbouche R, Abel L, Magdorf K, Gendrel D, Agou F, Holland SM, Casanova JL.

J Exp Med. 2006 Jul 10;203(7):1745-59. Epub 2006 Jul 3.

20.

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK.

Nature. 2006 May 11;441(7090):235-8. Epub 2006 Apr 30.

PMID:
16648838

Supplemental Content

Support Center